Clinical impact of PSMA-based 18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy.
about
Actual impact of 68Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence.Advances in prostate-specific membrane antigen PET of prostate cancer.Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review
P2860
Clinical impact of PSMA-based 18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Clinical impact of PSMA-based ...... r after primary local therapy.
@en
Clinical impact of PSMA-based ...... r after primary local therapy.
@nl
type
label
Clinical impact of PSMA-based ...... r after primary local therapy.
@en
Clinical impact of PSMA-based ...... r after primary local therapy.
@nl
prefLabel
Clinical impact of PSMA-based ...... r after primary local therapy.
@en
Clinical impact of PSMA-based ...... r after primary local therapy.
@nl
P2093
P2860
P1476
Clinical impact of PSMA-based ...... er after primary local therapy
@en
P2093
Alicia Forest
Anita T Ton
Baris Turkbey
Deborah Citrin
Ethan Bergvall
George Afari
Joanna H Shih
Juanita Weaver
Maria J Merino
Maria L Lindenberg
P2860
P2888
P356
10.1007/S00259-017-3818-X
P577
2017-09-11T00:00:00Z